EPH93 ASSOCIATIONS OF SOCIODEMOGRAPHIC AND CLINICAL FACTORS WITH GLP-1 RECEPTOR AGONIST UTILIZATION AMONG U.S. ADULTS WITH DIABETES, A CROSS-SECTIONAL ANALYSIS OF 2024 NHIS DATA
Value in Health · 2026-06 · 29 (6) · S181-S182
DOI: 10.1016/j.jval.2026.03.925 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Value in Health, 2026-06. Verfasst von Julianne A. Mercer und 3 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mercer, J. A., Encino, B. A., Lipscomb, J. S., & Lee, G. C. (2026). EPH93 ASSOCIATIONS OF SOCIODEMOGRAPHIC AND CLINICAL FACTORS WITH GLP-1 RECEPTOR AGONIST UTILIZATION AMONG U.S. ADULTS WITH DIABETES, A CROSS-SECTIONAL ANALYSIS OF 2024 NHIS DATA. Value in Health, 29(6), S181-S182. https://doi.org/10.1016/j.jval.2026.03.925
Vancouver
Mercer JA, Encino BA, Lipscomb JS, Lee GC. EPH93 ASSOCIATIONS OF SOCIODEMOGRAPHIC AND CLINICAL FACTORS WITH GLP-1 RECEPTOR AGONIST UTILIZATION AMONG U.S. ADULTS WITH DIABETES, A CROSS-SECTIONAL ANALYSIS OF 2024 NHIS DATA. Value in Health. 2026;29(6):S181-S182. doi:10.1016/j.jval.2026.03.925
BibTeX
@article{Mercer2026,
author = {Mercer, Julianne A. and Encino, Benjamin A. and Lipscomb, Justina S. and Lee, Grace C.},
title = {EPH93 ASSOCIATIONS OF SOCIODEMOGRAPHIC AND CLINICAL FACTORS WITH GLP-1 RECEPTOR AGONIST UTILIZATION AMONG U.S. ADULTS WITH DIABETES, A CROSS-SECTIONAL ANALYSIS OF 2024 NHIS DATA},
journal = {Value in Health},
year = {2026},
volume = {29},
number = {6},
pages = {S181--S182},
doi = {10.1016/j.jval.2026.03.925}
}
EUVIMED